EntryPoint Capital’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87.3K Sell
17,243
-664
-4% -$3.36K 0.04% 570
2025
Q1
$101K Buy
+17,907
New +$101K 0.05% 619